Surgical Treatment of Coronary Artery Disease: What Has Changed?

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Marc Ruel, MD, MPH
Disclosure(s): Medtronic: Proctor, MICS CABG (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Elaine Tseng, MD
Disclosure(s): Amgen Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion,: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Avania/Cellphire: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Portrero Med Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 28, 2022)

Presentations

  1. STS Perspective on Coronary Guidelines
    Joseph F. Sabik, III, MD
    Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)
     
  2. Why I Still Recommend CABG
    Michael Farkouh, MD, MSc
    Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
     
  3. FAME 3 Update
    Marc Ruel, MD, MPH
    Disclosure(s): Medtronic: Proctor, MICS CABG (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  4. Panel Discussion and Audience Q&A
     
  5. Prediction of competitive graft flow based on computed tomography-derived fractional flow reserve
    Min-Seok Kim, MD, PhD, MSc
     
  6. Invited Discussant
    Faisal G. Bakaeen, MD
     
  7. Effect of preoperative clopidogrel administration on outcomes of isolated CABG: Analysis of the National STS Adult Cardiac Surgery Database
    Kukbin Choi, MD
     
  8. Late Breaking: Multi-arterial Grafting Is Associated with Superior Long-Term Survival: Ten Year Follow-up of One Million Patients Following Coronary Artery Bypass Grafting
    Joseph F. Sabik, III, MD
    Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
5

Available Credit

  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Marc Ruel, MD, MPH
Disclosure(s): Medtronic: Proctor, MICS CABG (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Elaine Tseng, MD
Disclosure(s): Amgen Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion,: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Avania/Cellphire: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Portrero Med Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 28, 2022)

Presentations

  1. STS Perspective on Coronary Guidelines
    Joseph F. Sabik, III, MD
    Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)
     
  2. Why I Still Recommend CABG
    Michael Farkouh, MD, MSc
    Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); Novo Nordisk: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
     
  3. FAME 3 Update
    Marc Ruel, MD, MPH
    Disclosure(s): Medtronic: Proctor, MICS CABG (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  4. Panel Discussion and Audience Q&A
     
  5. Prediction of competitive graft flow based on computed tomography-derived fractional flow reserve
    Min-Seok Kim, MD, PhD, MSc
     
  6. Invited Discussant
    Faisal G. Bakaeen, MD
     
  7. Effect of preoperative clopidogrel administration on outcomes of isolated CABG: Analysis of the National STS Adult Cardiac Surgery Database
    Kukbin Choi, MD
     
  8. Late Breaking: Multi-arterial Grafting Is Associated with Superior Long-Term Survival: Ten Year Follow-up of One Million Patients Following Coronary Artery Bypass Grafting
    Joseph F. Sabik, III, MD
    Disclosure(s): Mectronic: Advisory Board (Ongoing), Speaker (Ongoing)